Top Growth Trends in the Drug And Gene Delivery Devices Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the drug and gene delivery devices market grown over the years?
The drug and gene delivery devices market has demonstrated strong growth, with expectations of rising from $0.61 billion in 2024 to $0.67 billion in 2025 at a CAGR of 9.0%. Contributing factors to past growth include advancements in healthcare infrastructure, the expansion of personalized gene therapy programs, a stronger focus on preventive healthcare, an emphasis on rare and orphan diseases, and increased public awareness regarding treatment options.
What Is the forecasted market size and growth rate for the drug and gene delivery devices market?
The drug and gene delivery devices market is projected to expand significantly, reaching $0.93 billion in 2029 at a CAGR of 8.7%. Growth will be fueled by rising chronic disease cases, demand for personalized medicine, growing awareness of gene therapy, preference for minimally invasive procedures, and the shift towards direct-to-patient delivery models. Key trends include biotechnology advancements, innovations in drug delivery systems, increased R&D investment, new delivery platforms, and progress in diagnostic technologies.
Get your drug and gene delivery devices market report here!
What are the major factors driving growth in the drug and gene delivery devices market?
The rising adoption of gene therapy is boosting the drug and gene delivery devices market. Gene therapy offers transformative treatment for genetic and chronic diseases, where conventional therapies may be inadequate. Drug and gene delivery devices ensure precise targeting and controlled release of therapeutic genes. According to the National Centre for Biotechnology Information, the number of new patients treated with gene therapies is projected to rise from 16,244 in 2020 to 94,696 in 2025. Thus, growing gene therapy adoption is fueling the drug and gene delivery devices market.
What key areas define the segmentation of the global drug and gene delivery devices Market?
The drug and gene delivery devicesmarket covered in this report is segmented –
1) By Vector: Viral, Non-viral
2) By Method: In Situ, Ex Vivo
3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
Subsegments:
1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp
What are the top market players propelling the growth of the drug and gene delivery devices industry?
Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics
What are the key trends shaping the future of the drug and gene delivery devices market?
Prominent businesses in the drug and gene delivery devices sector are concentrating on the advancement of cutting edge products like artificial intelligence (AI) technology to secure a market advantage. AI technology applicable to drug delivery embodies the use of AI tactics and computations to heighten the accuracy, efficiency, and effectiveness of drug delivery systems. To exemplify, in December 2023, Envoya Inc., an organization based in the US well-known for its development of polymer-based nanoparticles for targeted delivery, unveiled a pioneering gene therapy drug delivery platform. The platform, merging biopolymer-nanoparticles with AI, aims to tackle significant drawbacks present in current gene therapy technologies, such as viral vectors and lipid nanoparticles. It’s been designed to not just ensure safety but also to address issues related to limited payload capacities and tissue targeting that have been a challenge with existing gene therapy delivery technologies.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19404
What regions are dominating the drug and gene delivery devices market growth?
North America was the largest region in the drug and gene delivery devices market in 2024. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Hematology Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report
Respiratory Diseases Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report
Metabolic Disorders Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
